Imanext and CNServices Form Long-Term Collaboration

Press release, Helsinki and Kuopio:

CNServices Ltd (based in Kuopio, Finland) and Imanext Ltd (based in Helsinki and Kuopio) enter into long-term collaboration in client services and marketing. The collaboration covers nonclinical CNS imaging studies (SPECT and MRI) conducted in Kuopio with state-of-art disease models and histology services.

CNServices is one of the leading providers of animal models for CNS diseases, histology and techniques for the development of novel pharmacotherapies particularly for epilepsy, stroke and neurodegenerative disorders.

Imanext offers niche nonclinical and clinical study services in the field of Functional Imaging; PET/CT, SPECT/CT, MRI, Ultrasound and Optical Imaging. Imanext has established significant, multinational network of imaging sites for conducting demanding imaging research projects. Imanext has also gained ample amount resources for successful management of translational and also clinical multi-centre imaging studies for customers.

Jukka Jolkkonen (CNServices), +358 40 5383974 or
Kim Bergström (Imanext), +358 40 415 5741.

Imanext Ltd is a specialized Contract Research Organization operating in the field of Molecular Imaging. Imanext provides design and execution of nonclinical and clinical imaging trials and related research services to the pharmaceutical and food industry. Imanext offers state-of-art imaging methods (PET/CT, SPECT/CT, μPET/CT, μSPECT/CT, MRI, Ultrasound, Optical Imaging) in all continents. Imanext has global access to validated cGMP imaging biomarkers. The company also develops innovative radioactive tracers.
www.imanext.com

CNServices Ltd offers valid animal models and state-of-art techniques for the development of novel pharmacotherapies for epilepsy, stroke, and neurodegenerative diseases such as Alzheimer's disease. All models have been validated in a research-based environment and published in international scientific journals. All services are tailored to the customer's need.
www.cnservices.com.